Top 25 BSCI/BSCCT research priorities in descending order
| Priority | Research question |
| 1 | Is there a combination of stenosis/CTFFR/plaque features that identify a situation where the benefit of a stent outweighs its risks? |
| 2 | How can we best target cardiac imaging to optimise its yield in terms of outcomes and economic costs? |
| 3 | Is there a mortality/morbidity reduction through the wider use of CTCA? |
| 4 | What is the optimum imaging/investigative strategy in acute coronary syndromes? |
| 5 | What are the outcomes of CTCA use in low-risk ACS patients? |
| 6 | How can we limit increases in downstream costs and healthcare utilisation after CTCA? |
| 7 | What are the optimal features/markers of the vulnerable plaque? |
| 8 | What is the role of CTFFR in clinical practice? |
| 9 | Can we identify and characterise biomarkers of sudden cardiac death/arrhythmias in order to develop better risk stratification tools? |
| 10 | What is the economic impact of CTFFR in routine practice? |
| 11 | Can we standardise advanced MRI techniques (eg, late gadolinium enhancement quantification, mapping)? |
| 12 | How do different cardiac imaging strategies affect downstream testing? |
| 13 | How useful are TAVI (Transcatheter Aortic Valve Implantation) CTs in management decisions when many people who are worked up don't end up getting TAVI, is there a more cost-effective strategy to predict who needs TAVI CT? |
| 14 | Can cardiovascular imaging be used to predict/improve outcomes in cardiomyopathy imaging? |
| 15 | How can we reduce the impact of calcification on CTCA diagnostic accuracy, in a radiation and time-efficient manner? |
| 16 | Can we use artificial intelligence to enable decision support tools for the use of cardiovascular imaging? |
| 17 | What is the optimum follow-up interval for imaging of cardiovascular disease (eg, aneurysms, dissection)? |
| 18 | Can CTCA replace functional imaging for stable angina? |
| 19 | Can we develop methods to improve accuracy in CTCA assessment of in-stent disease? |
| 20 | What is the role of artificial intelligence in cardiovascular disease? |
| 21 | Is there a role for early use of cardiac CT in confirmed/high-risk ACS? |
| 22 | What are the barriers to the implementation of evidence-based imaging strategies in cardiovascular imaging? |
| 23 | Which patients do not need or derive no benefit from cardiovascular imaging? |
| 24 | Do any advanced imaging modalities improve outcome in dilated cardiomyopathy? |
| 25 | Has the change of the NICE guidance resulted in more inappropriate CTCA referrals? |
BSCI/BSCCT, British Society for Cardiac Imaging/British Society of Cardiac CT; NICE, National Institute for Health and Care Excellence.